Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index; 19 of the 30 sources its claims cite were checked for support.
Abstract
The inherited peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), associated with neurodegeneration and inflammatory cerebral demyelination, is caused by mutations in the ABCD1 gene encoding the peroxisomal ATP-binding cassette (ABC) transporter ABCD1 (ALDP). ABCD1 transports CoA-esters of very long-chain fatty acids (VLCFA) into peroxisomes for degradation by β-oxidation; thus, ABCD1 deficiency results in VLCFA accumulation. The closest homologue, ABCD2 (ALDRP), when overexpressed, compensates for ABCD1 deficiency in X-ALD fibroblasts and in Abcd1-deficient mice. Microglia/macrophages have emerged as important players in the progression of neuroinflammation. Human monocytes, lacking significant expression of ABCD2, display severely impaired VLCFA metabolism in X-ALD. Here, we used thioglycollate-elicited primary mouse peritoneal macrophages (MPMΦ) from Abcd1 and Abcd2 single- and double-deficient mice to establish how these mutations affect VLCFA metabolism. By quantitative RT-PCR, Abcd2 mRNA was about half as abundant as Abcd1 mRNA in wild-type and similarly abundant in Abcd1-deficient MPMΦ. VLCFA (C26∶0) accumulated about twofold in Abcd1-deficient MPMΦ compared with wild-type controls, as measured by gas chromatography-mass spectrometry. In Abcd2-deficient macrophages VLCFA levels were normal. However, upon Abcd1/Abcd2 double-deficiency, VLCFA accumulation was markedly increased (sixfold) compared with Abcd1-deficient MPMΦ. Elovl1 mRNA, encoding the rate-limiting enzyme for elongation of VLCFA, was equally abundant across all genotypes. Peroxisomal β-oxidation of C26∶0 amounted to 62% of wild-type activity in Abcd1-deficient MPMΦ and was significantly more impaired (29% residual activity) upon Abcd1/Abcd2 double-deficiency. Single Abcd2 deficiency did not significantly compromise β-oxidation of C26∶0. Thus, the striking accumulation of VLCFA in double-deficient MPMΦ compared with single Abcd1 deficiency was due to the loss of ABCD2-mediated, compensatory transport of VLCFA into peroxisomes. We propose that moderate endogenous expression of Abcd2 in Abcd1-deficient murine macrophages prevents the severe metabolic phenotype observed in human X-ALD monocytes, which lack appreciable expression of ABCD2. This supports upregulation of ABCD2 as a therapeutic concept in X-ALD.
Overview
CoChat Summary
TL;DR
In Abcd1-deficient mouse peritoneal macrophages, endogenous Abcd2 expression at about half the level of Abcd1 substantially compensates for loss of ABCD1, limiting VLCFA accumulation and preserving peroxisomal β-oxidation. Combined Abcd1/Abcd2 deficiency causes a much more severe metabolic phenotype, supporting ABCD2 upregulation as a therapeutic concept in X-linked adrenoleukodystrophy.
Key findings
- In wild-type mouse peritoneal macrophages, Abcd2 mRNA was present at 58% of Abcd1 mRNA; Abcd2 mRNA levels were not significantly changed in Abcd1-deficient macrophages.
- C26:0 accumulated about twofold in Abcd1-deficient macrophages versus wild-type, but was normal in Abcd2-deficient macrophages; Abcd1/Abcd2 double deficiency increased C26:0 accumulation sixfold compared with Abcd1 deficiency alone, or about twelvefold versus wild-type.
- Peroxisomal β-oxidation of C26:0 was 62% of wild-type activity in Abcd1-deficient macrophages and fell to 29% residual activity in Abcd1/Abcd2 double-deficient macrophages; single Abcd2 deficiency did not significantly impair C26:0 β-oxidation.
- Elovl1 mRNA was equally abundant across all genotypes, and C16:0 β-oxidation was similar across genotypes, suggesting the double-deficiency phenotype was due mainly to loss of ABCD2-mediated compensatory VLCFA transport into peroxisomes.
Methods
- Abcd2-deficient mice were generated by targeted inactivation and crossed with Abcd1-deficient mice on the C57BL/6J background; adult 3–6-month-old male mice were used to isolate thioglycollate-elicited primary mouse peritoneal macrophages.
- mRNA levels for Abcd1, Abcd2, and Elovl1 were measured by quantitative RT-PCR and normalized to Hprt; VLCFA species C26:0, C24:0, C22:0, and C16:0 were measured by GC-MS.
- Peroxisomal β-oxidation was assayed using 1-14C-labelled C26:0 and C16:0; statistical analyses used t-tests or one-way ANOVA with post-hoc tests, with significance at p<0.05.
Limitations
- The authors state that the findings cannot be directly translated to human perivascular or parenchymal macrophages or activated microglia in X-ALD brain lesions, and that species differences may contribute to the lack of cerebral inflammatory phenotype in mouse models.
- The authors note they cannot exclude altered ELOVL1 enzymatic activity or substrate availability, although they consider a major contribution unlikely given the impaired VLCFA degradation.
- Evident from the text: many experiments used n=3, only male mice were studied, and thioglycollate-elicited peritoneal macrophages may differ from resident macrophages or microglia; the paper also notes possible eosinophil contamination in such preparations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
13 Valid · 1 Not valid · 8 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In contrast to primary mouse peritoneal macrophages, primary human monocytes/macrophages virtually lack ABCD2 gene expression [40], [41].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Could not verifycites [40] T Langmann, 2006, Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation, Clin Chem sourceExperimental — accuracy not yet measured
The Results say that 30 ABC transporters had detectable mRNA in human primary monocytes and refer to Table 1, but the passages available from our copy do not identify ABCD2 as expressed or unexpressed. Searches for ABCD2 and for its absence in monocytes/macrophages found no gene-specific result; the Table 1 passage contains only its caption and notes. (LLM, conf=0.72)
- Supportedcites [41] FD Weber, 2014, X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes, Hum Mol Genet source
The Results section reports that ABCD2 mRNA was barely detectable in primary human monocytes (Fig. 1A). The Discussion adds that differentiation of monocytes into macrophages did not change this status: ABCD2 expression remained below the level defined as expressed. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in contrast to human monocytes [41] or human fibroblasts [7], in the absence of ABCD1, sufficient amounts of endogenous ABCD2 are present to maintain a substantial β-oxidation capacity for VLCFA substrates (62% of wild-type β-oxidation activity for C26∶0, Fig. 5).”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Supportedcites [41] FD Weber, 2014, X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes, Hum Mol Genet source
The citation [41] supports the contrast with human monocytes, not the subsequent result for murine macrophages. The Discussion reports that ABCD2 is barely expressed in monocytes and that C26:0 β-oxidation in X-ALD monocytes is reduced to less than 30% of control values. The 62% figure is presented as the citing paper’s Fig. 5 result, not as a finding attributed to this source. (LLM, conf=0.93)
- Supportedcites [7] C Wiesinger, 2013, Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction, J Biol Chem source
The citation [7] is attached to the contrast with human fibroblasts, not to the murine macrophage result or the 62% figure. The Discussion states that ABCD2 is virtually absent in human fibroblasts and that they show a pronounced VLCFA β-oxidation deficit. The murine percentage is presented as the citing paper’s own Fig. 5 result. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recently, we obtained evidence showing that the feasibility to induce ABCD2 depends on the differentiation state in the human monocyte/macrophage lineage [66].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Supportedcites [66] FD Weber, 2014, Evaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy, PLoS ONE source
The Results section reports that 13CRA induced ABCD2 in differentiated human monocyte-derived macrophages. The Discussion contrasts this with unchanged ABCD2 levels in primary monocytes from 13CRA-treated patients, supporting the claim that inducibility differs with differentiation state. The comparison involves different treatment settings, so it does not isolate differentiation as the cause. (LLM, conf=0.87)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Compared with wild-type levels, we found a two-fold increase in the ratio C26∶0/C22∶0 (Fig. 3A).”
- Also stated in: § Discussion · plain
“Our results revealed about twofold higher levels of VLCFA in Abcd1-deficient MPMΦ, as judged by the ratio C26∶0/C22∶0, in agreement with previous observations [27].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Results > Inactivation of Abcd2 alone has no impact on VLCFA levels of MPMΦ but a strong synergistic effect in combined Abcd1/Abcd2 deficiency
What the sources say
- Partly supportedcites [27] N Yanagisawa, 2008, Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages, Lipids Health Dis sourceExperimental — accuracy not yet measured
The Results section, “Quantification of C26:0” (page unavailable), reports that the C26:0/C22:0 ratio in macrophages from ALDP-deficient mice was significantly higher than in wild-type mice. Our copy does not give a numerical ratio or establish the claimed two-fold increase. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The most likely candidate for mediating the residual β-oxidation activity (29%) for C26∶0 in the Abcd1/Abcd2 double-deficient MPMΦ is the third peroxisomal ABC transporter, ABCD3, in similarity to human X-ALD fibroblasts [7] and monocytes [41].”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Discussion
What the sources say
- Supportedcites [7] C Wiesinger, 2013, Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction, J Biol Chem source
The Discussion states that ABCD3 is responsible for most residual VLCFA β-oxidation in human X-ALD fibroblasts, supporting the fibroblast comparison for which this source is cited. The mouse macrophage result and monocyte comparison are not attributed to this citation. (LLM, conf=0.92)
- Partly supportedcites [41] FD Weber, 2014, X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes, Hum Mol Genet sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
39 more claims · 2 with their cited sources checked
Create a free account to see all 73 claims and every source verdict.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is intriguing that also Abcd1/Abcd2 double-deficient mice do not develop brain inflammation or demyelination [156], in spite of the finding that Abcd1/Abcd2 double-deficient peritoneal macrophages are metabolically much more severely affected than those from single transporter-deficient mice [157]. Also in these mice, the neuropathology is restricted mainly to axonopathy in the spinal cord and,”
From Peroxisomes in brain development and function (2016) · cites this paper as [157]
The cited source says what the claim attributes to it.
In the citing paper
“Upon overexpression, ABCD2101–104 and, to some extent, ABCD35,102,105 can compensate for the lack of ABCD1 in vivo and in vitro, and therefore represent excellent candidates for a modulation of the phenotype.”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Materials and Methods > Construction of the Abcd2 targeting vector
“a 2.1-kb NdeI− SphI fragment (−2.5 kb to −422 relative to the translation start site of Abcd2) representing the 5′ (short) Abcd2 homology region”
§ Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice > Results > Targeted inactivation of the murine Abcd2 gene
“Between the “short arm” (3.5 kb of DNA upstream from exon 1) and the “long arm” (6 kb from the 3′ end of exon 1 through intron 3) of the targeting vector”
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331 · cited 1×
“Protein concentration was determined by the method of Lowry using bovine serum albumin (Sigma-Aldrich) as standard [56].”
MethodSingle-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA was isolated from flash frozen tissues [53] of 2.”
MethodDerivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329 · cited 1×
“Mouse RI embryonic stem (ES) cells [51], kindly provided by A.”
BackgroundMansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
The Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536 · cited 1×
“from wild-type and knock-out mice as described in [55] with some”
MethodHematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 1×
“Allogeneic bone marrow transplantation or hematopoietic stem cell transplantation [36,37] and also gene therapy of autologous CD34 hematopoietic stem cells, providing intact ABCD1, can arrest the inflammatory cerebral demyelination in patients at early stages of cerebral ALD [38].”
BackgroundPutative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · cited 1×
“Genome-wide transcriptome analysis indicates that thioglycollate-induced macrophages are closely related to microglial cells as well as to bone marrow derived macrophages [49].”
BackgroundFatty acid elongases in mammals: their regulation and roles in metabolism
JAKOBSSON, A., WESTERBERG, R., & JACOBSSON, A. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.01.004 · Cited by 936 · cited 2×
“long-chain fatty acids (ELOVL), mediates the substrate-selective step of the elongation pathway [12].”
BackgroundTwo physically, functionally, and developmentally distinct peritoneal macrophage subsets
Ghosn, E. E. B., Cassado, A. A., Govoni, G. R., Fukuhara, T., Yang, Y., Monack, D. M., Bortoluci, K. R., Almeida, S. R., Herzenberg, L. A., & Herzenberg, L. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915000107 · Cited by 689 · cited 1×
“These differ in size, surface markers and function from the residential peritoneal macrophages but show similar phagocytic activity [48].”
Background
Research works printed but not linked: 1
- Van Roermund CW, Ijlst L, Wagemans T, Wanders RJ, Waterham HR (2013) A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. Biochim Biophys Acta. · DOI · Paper page
Cited by
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
“It is intriguing that also Abcd1/Abcd2 double-deficient mice do not develop brain inflammation or demyelination [156], in spite of the finding that Abcd1/Abcd2 double-deficient peritoneal macrophages are metabolically much more severely affected than those from single transporterdeficientmice [157].”
BackgroundSelf-citationBerger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140
Self-citationPeroxisomes in Immune Response and Inflammation
Cara, F. D., Andreoletti, P., Trompier, D., Véjux, A., Bülow, M. H., Sellin, J., Lizard, G., Cherkaoui‐Malki, M., & Savary, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163877 · Cited by 142
“Consistently, a higher accumulation of VLCFA was shown in Abcd1/Abcd2 double-deficient mouse peritoneal macrophage, compared to the single Abcd1 deficiency [54].”
BackgroundBrain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92
“MYC silencing mimic the effect of”
BackgroundFourcade, S., Ferrer, I., & Pujol, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.041 · Cited by 76
Metadata
- Authors
- Muneer, Z., Wiesinger, C., Voigtländer, T., Werner, H. B., Berger, J., & Forss-Petter, S.
- Affiliations
- Medical University of Vienna (AT)
- Max Planck Institute of Experimental Medicine (DE)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-09-25
- Volume
- 9
- Issue
- 9
- Pages
- e108655
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4177892
- OpenAlex
- W2095313254
- Cited by
- 33
- References
- 68
- Citations by year
- 2026: 2 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 1 · 2015: 5
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- European Commission (241622, FP7-HEALTH-2009)
- Austrian Science Fund (P26112, P26112-B19,)
- Higher Education Commision, Pakistan
- FP7 Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- X-linked adrenoleukodystrophy, ABCD1, ABCD2, very long chain fatty acids, peroxisomal beta-oxidation, peritoneal macrophages, ELOVL1, peroxisomal disorders, genetic modifiers, neuroinflammation
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, ATP Binding Cassette Transporter, Subfamily D, Member 1, Fatty Acid Elongases, Long-Chain-Fatty-Acid-CoA Ligase, Acetyltransferases, Animals, Coenzyme A Ligases, Fatty Acids, Gene Expression Regulation, Genetic Vectors, Male, Oxidation-Reduction, RNA, Messenger, Macrophages, Peritoneal, Mice, Knockout, Gene Targeting, ATP-Binding Cassette Transporters, Peroxisomes, Gene Silencing, Gene Order, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice. https://app.cochat.ai/papers/10.1371/journal.pone.0108655
- The paper
- Muneer, Z., Wiesinger, C., Voigtländer, T., Werner, H. B., Berger, J., & Forss-Petter, S. (2014). Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice. PLoS ONE. https://doi.org/10.1371/journal.pone.0108655
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.